Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains.

Antimicrobial agents and chemotherapy - 1 Jun 2014

Jensen Jørgen Skov, Fernandes Prabhavathi, Unemo Magnus

Abstract excerpt

Mycoplasma genitalium has become well established as an etiological agent of sexually transmitted infections, but due to its fastidious growth requirements, only a few M. genitalium strains are available to determine the MICs of currently used and new antimicrobial agents. Recent clinical trials have suggested that treatment with azithromycin has decreasing efficacy due to an increasing prevalence of macrolide...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Azithromycin
Share to Doxycycline

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gonorrhea

Share to Moxifloxacin

Share to Mycoplasma genitalium

Share to Mycoplasma Infections

Share to Neisseria gonorrhoeae

Share to Triazoles

Source

Open in PubMed Open full text

Identifiers

PMID: 24637681
DOI: 10.1128/AAC.02411-14
PMCID: PMC4068426

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains.PMID 24637681Read ↗

Prolonged sitafloxacin and doxycycline combination regimen for treating infections by highly resistant Mycoplasma genitalium.Semantic proximity Read ↗

Multiplex Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance Using PlexZyme and PlexPrime TechnologySemantic proximity Read ↗

Macrolide resistance in Mycoplasma genitalium from female sex workers in Belgium.Semantic proximity Read ↗

Effectiveness of sitafloxacin monotherapy for quinolone-resistant rectal and urogenital Mycoplasma genitalium infections: a prospective cohort study.Semantic proximity Read ↗

Macrolide and fluoroquinolone resistance of Mycoplasma genitalium in southern Spain, 2018-2019.Semantic proximity Read ↗

Prospective Evaluation of ResistancePlus MG, a New Multiplex Quantitative PCR Assay for Detection of Mycoplasma genitalium and Macrolide ResistanceSemantic proximity Read ↗

Efficacy of Doxycycline-Sitafloxacin Sequential Therapy for Urogenital Mycoplasma genitalium Infection in Nanjing, China.Semantic proximity Read ↗

In vitro selection and characterization of resistance to pristinamycin in Mycoplasma genitalium.Semantic proximity Read ↗

Detection of macrolide resistance in Mycoplasma genitalium in France.Semantic proximity Read ↗

Mycoplasma genitalium and Macrolide Resistance-associated Mutations in the Skåne Region of Southern Sweden 2015.Semantic proximity Read ↗

In vitro-induced erythromycin resistance facilitates cross-resistance to the novel fluoroketolide, solithromycin, in Staphylococcus aureus.Semantic proximity Read ↗

Which azithromycin regimen should be used for treating Mycoplasma genitalium? A meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.